Albany Molecular Research files $50 million stock, preferreds shelf

By Devika Patel

Knoxville, Tenn., Dec. 22 - Albany Molecular Research, Inc. filed a $50 million shelf registration in an S-3 filing with the Securities and Exchange Commission.

The registration covers common stock, warrants, units and preferred stock.

The preferreds may be structured as convertibles.

Proceeds will be used for general corporate purposes.

Albany, N.Y.-based Albany Molecular Research is a global drug discovery company that provides chemistry services to pharmaceutical and biotechnology companies.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.